MOLECULAR MECHANISMS OF RENAL INJURY
MOLECULAR MECHANISMS OF RENAL INJURY
批准号:
6380725
负责人:
MICHAEL P MADAIO
金额:
$72.5万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 2003-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Basement membranes are composed of type IV collagen, laminins,
proteoglycans and entactin. Type IV collagen comprises a family of six
different alpha-chains. Glomerular basement membrane (GBM) collagen,
for example, is formed in two phases with alpha-3(IV), and alpha-5(IV)
collagens appearing later and eventually dominating protomers initially
formed from alpha-1 (IV) and alpha-2(IV) chains. Basement membranes
from liver, in contradistinction, do not normally express alpha-5(IV) or
alpha-6(IV) collagens after their initial formation.
This switch from fetal alpha-1 (IV) and alpha-2(IV) collagens to alpha-
3(IV), alpha-4(IV), and alpha-5(IV) chains in human GBM is a
developmental event that advances the fabrication of capillary loops in
the glomerulus. We believe this developmental switch improves the
structural integrity of the capillary filter by protectively enhancing its
resistance to local proteases at the site of glomerular filtration. This
switch is defective in most kidneys from patients with x-linked Alport
Syndrome (XAS) who have mutations in the alpha-5(IV) gene and go on
to renal failure.
We propose to examine the mechanism of this developmental switch by
studying the supramolecular control of the alpha-5(IV) collagen gene.
We hypothesize that switching is gated by the opening of chromatin in
selected tissues, and is under the modular control of DNA-binding
proteins. Determining coordinates for these locus control regions (LCRs)
is the first step in understanding the larger aspects of this regulatory
process.
Regulatory regions important for the switching of type IV collagen will
be studied by mapping unique DNasel hypersensitive sites in kidney
chromatin remote to the start of the human alpha-5(IV) gene. We have
obtained a BAC clone containing genomic DNA from this region on
chromosome Xq22.2, and have developed a strategy for measuring
human alpha-5(IV) transcripts in transgenic mice. Candidate
hypersensitive sites will be expressed as transgenes and evaluated for
functional activity, switching, position-independence and copy number-
dependence. Hypersensitive sites identified as LCRs can then e
explored at the level of the nucleosome in subsequent, second-order
studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modified Human Anti-a(3) IV Antibodies for Drug Delivery in Nephritis
-
批准号:7937993
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2009
-
负责人:MICHAEL P MADAIO
-
依托单位:
Modified Human Anti-a(3) IV Antibodies for Drug Delivery in Nephritis
-
批准号:7590226
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2009
-
负责人:MICHAEL P MADAIO
-
依托单位:
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES
-
批准号:6600445
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2002
-
负责人:MICHAEL P MADAIO
-
依托单位:
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES
-
批准号:6480435
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2001
-
负责人:MICHAEL P MADAIO
-
依托单位:
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES
-
批准号:6340871
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2000
-
负责人:MICHAEL P MADAIO
-
依托单位:
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES
-
批准号:6201875
-
项目类别:
-
资助金额:$16.88万
-
财政年份:1999
-
负责人:MICHAEL P MADAIO
-
依托单位:
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES
-
批准号:6105526
-
项目类别:
-
资助金额:$16.88万
-
财政年份:1998
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR ANALYSIS OF HUMAN ANTIGBM ANTIBODIES
-
批准号:6569397
-
项目类别:
-
资助金额:$3.96万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR ANALYSIS OF HUMAN ANTIGBM ANTIBODIES
-
批准号:2770659
-
项目类别:
-
资助金额:$24.38万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR ANALYSIS OF HUMAN ANTIGBM ANTIBODIES
-
批准号:2397545
-
项目类别:
-
资助金额:$20.3万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES
-
批准号:6239069
-
项目类别:
-
资助金额:$17.39万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
Molecular Analysis of Human Anti-GBM Antibodies
-
批准号:6788102
-
项目类别:
-
资助金额:$24.57万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
Molecular Analysis of Human Anti-GBM Antibodies
-
批准号:6901130
-
项目类别:
-
资助金额:$24.57万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
Molecular Analysis of Human Anti-GBM Antibodies
-
批准号:6541662
-
项目类别:
-
资助金额:$30.27万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR ANALYSIS OF HUMAN ANTIGBM ANTIBODIES
-
批准号:6177811
-
项目类别:
-
资助金额:$25.79万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
Molecular Analysis of Human Anti-GBM Antibodies
-
批准号:6617838
-
项目类别:
-
资助金额:$24.57万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR ANALYSIS OF HUMAN ANTIGBM ANTIBODIES
-
批准号:2906113
-
项目类别:
-
资助金额:$25.04万
-
财政年份:1997
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR MECHANISMS OF RENAL INJURY
-
批准号:6177181
-
项目类别:
-
资助金额:$72.5万
-
财政年份:1992
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR MECHANISMS OF RENAL INJURY
-
批准号:2905489
-
项目类别:
-
资助金额:$72.5万
-
财政年份:1992
-
负责人:MICHAEL P MADAIO
-
依托单位:
MOLECULAR MECHANISMS OF RENAL INJURY
-
批准号:2749479
-
项目类别:
-
资助金额:$67.5万
-
财政年份:1992
-
负责人:MICHAEL P MADAIO
-
依托单位:
海外基金